"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.

Journal Article (Journal Article)

Many people living with HIV (PLWHIV) state that they would be willing to take significant risks to be "cured" of the virus. However, how they interpret the word "cure" in this context is not clear. We used a randomized survey to examine whether PLWHIV had a different willingness to take a hypothetical HIV medication if it causes flu-like symptoms, but provides: (a) cure, (b) remission that was labeled "cure", or (c) remission. PLWHIV (n = 454) were more willing to take a medication that provided a "cure" versus a "remission" if the side effects lasted less than 1 year. PLWHIV were more willing to take a medication that provided a remission that was labeled "cure" versus a "remission" (p = 0.01) if the side effects lasted 2 weeks. Clinicians and researchers should be aware of the impact of the word "cure" and ensure that PLWHIV fully understand the possible outcomes of their treatment options.

Full Text

Duke Authors

Cited Authors

  • Fridman, I; Ubel, PA; Blumenthal-Barby, J; England, CV; Currier, JS; Eyal, N; Freedberg, KA; Halpern, SD; Kelley, CF; Kuritzkes, DR; Le, CN; Lennox, JL; Pollak, KI; Zikmund-Fisher, BJ; Scherr, KA

Published Date

  • July 2020

Published In

Volume / Issue

  • 24 / 7

Start / End Page

  • 2054 - 2061

PubMed ID

  • 31900813

Pubmed Central ID

  • PMC7319892

Electronic International Standard Serial Number (EISSN)

  • 1573-3254

Digital Object Identifier (DOI)

  • 10.1007/s10461-019-02769-1


  • eng

Conference Location

  • United States